LH · Labcorp Holdings Inc.
$318.13
-4.46 (-1.38%)
At close · Aug 14
Market Cap
$25.80B
Shares
81.10M
Labcorp Holdings Inc. Earnings Call Transcripts
Every quarterly earnings call for Labcorp Holdings Inc. (LH) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▼29.4%
$2.87B
$352.80M
'22 Q3
22-10-27
▲103%
$2.17B
$76.10M
'22 Q4
23-02-16
▼22.1%
$3.04B
$212.90M
'23 Q1
23-04-25
▲3.8%
$3.03B
$188.90M
'23 Q2
23-07-27
▲6.6%
$3.06B
$183.30M
'23 Q3
23-10-26
▲39.5%
$3.03B
−$167.10M
'23 Q4
24-02-15
▲4.6%
$3.18B
$228.00M
'24 Q1
24-04-25
▲6.2%
$3.22B
$205.30M
'24 Q2
24-08-01
▲7.4%
$3.28B
$169.30M
'24 Q3
24-10-24
▲9.8%
$3.33B
$143.40M
'24 Q4
25-02-06
▲5.3%
$3.35B
$212.80M
'25 Q1
25-04-29
▲9.5%
$3.53B
$237.90M
'25 Q2
25-07-24
▲8.6%
$3.56B
$261.10M
'25 Q3
25-10-28
▲5.6%
$3.52B
$164.70M
'25 Q4
26-02-17
▲5.8%
$3.54B
$277.80M
'26 Q1
26-04-30
LATEST
▲5.8%
$3.73B
$298.70M
'26 Q2
26-07-30
Earnings call
FY26 · Q2
2026-07-30
Q2 2026 Labcorp Holdings Inc. Earnings Conference Call
Confident tone
Biopharma Laboratory Services (BLS)
Specialty Testing / Oncology Expansion
PAMA / Regulatory & Legislative Risk
Revenue
$3.73B
▲ 5.8% YoY Diluted EPS
$3.64
▲ 28.2% YoY Gross margin
29.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Labcorp Holdings Inc. at the Jefferies Global Healthcare Conference in New York
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
Labcorp Holdings Inc. Q1 FY2026 Earnings Call
Confident tone
Margin expansion and Launchpad productivity
Consumer health and digital engagement
Specialty testing growth areas
Revenue
$3.54B
▲ 5.8% YoY Diluted EPS
$3.35
▲ 32.9% YoY Gross margin
28.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-17
Labcorp Holdings Inc. Q4 FY2025 Earnings Call
Confident tone
Early Development/BLS
Specialty/Esoteric Testing Growth
2025 Financial Results
Revenue
$3.52B*
▲ 5.6% YoY Gross margin
28.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Labcorp Holdings Inc. Q3 FY2025 Earnings Call
Confident tone
Early Development weakness and restructuring
Invitae integration
Biopharma Laboratory Services (Central Lab)
Revenue
$3.56B
▲ 8.6% YoY Diluted EPS
$3.12
▲ 56% YoY Gross margin
28.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-24
Labcorp Holdings Inc. Q2 FY2025 Earnings Call
Confident tone
Biopharma Laboratory Services (BLS) momentum
Diagnostics Laboratories segment growth
PAMA reimbursement risk
Revenue
$3.53B
▲ 9.5% YoY Diluted EPS
$2.84
▲ 16.9% YoY Gross margin
29.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Labcorp Holdings Inc. Q1 FY2025 Earnings Call
Confident tone
Biopharma Laboratory Services (BLS)
2025 financial guidance
Diagnostics Laboratories growth and margin
Revenue
$3.35B
▲ 5.3% YoY Diluted EPS
$2.52
▼ 6.3% YoY Gross margin
28.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-06
Labcorp Holdings Inc. Q4 FY2024 Earnings Call
Confident tone
2024 financial performance
Strategic acquisitions and Invitae integration
2025 guidance and outlook
Revenue
$3.33B*
▲ 9.8% YoY Gross margin
26.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-24
Labcorp Holdings Inc. Q3 FY2024 Earnings Call
Positive tone
Acquisitions and Partnerships
Diagnostics and Biopharma Growth
Book-to-Bill and Early Development
Revenue
$3.28B
▲ 7.4% YoY Diluted EPS
$2.00
▼ 5.2% YoY Gross margin
27.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
Labcorp Holdings Inc. Q2 FY2024 Earnings Call
Confident tone
Invitae acquisition
2024 guidance and margins
LaunchPad cost initiative
Revenue
$3.22B
▲ 6.2% YoY Diluted EPS
$2.43
▲ 14.6% YoY Gross margin
28.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-25
Labcorp Holdings Inc. Q1 FY2024 Earnings Call
Confident tone
Quarterly Financial Results & Guidance
Diagnostics Margin Pressure
Early Development Biopharma Weakness
Revenue
$3.18B
▲ 4.6% YoY Diluted EPS
$2.69
▲ 12.6% YoY Gross margin
28.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-15
Labcorp Holdings Inc. Q4 FY2023 Earnings Call
Confident tone
Biopharma laboratory services
2024 financial guidance
Diagnostics base business growth
Revenue
$3.03B*
▲ 39.5% YoY Gross margin
27.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-26
Labcorp Holdings Inc. Q3 FY2023 Earnings Call
Revenue
$3.06B
▲ 6.6% YoY Diluted EPS
$2.11
▼ 45.9% YoY Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Labcorp Holdings Inc. Q2 FY2023 Earnings Call
Revenue
$3.03B
▲ 3.8% YoY Diluted EPS
$2.12
▼ 45.2% YoY Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
Labcorp Holdings Inc. Q1 FY2023 Earnings Call
Revenue
$3.04B
▼ 22.1% YoY Diluted EPS
$2.39
▼ 46.8% YoY Gross margin
28.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-16
Labcorp Holdings Inc. Q4 FY2022 Earnings Call
Revenue
$2.17B*
▲ 103% YoY Gross margin
29.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-10-27
Labcorp Holdings Inc. Q3 FY2022 Earnings Call
Revenue
$2.87B
▼ 29.4% YoY Diluted EPS
$3.90
▼ 25% YoY Gross margin
30.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-07-28
Labcorp Holdings Inc. Q2 FY2022 Earnings Call
Revenue
$2.92B
▼ 23.9% YoY Diluted EPS
$3.87
▼ 5.4% YoY Gross margin
32.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Labcorp Holdings Inc. Q1 FY2022 Earnings Call
Revenue
$3.90B
▼ 6.3% YoY Diluted EPS
$4.49
▼ 33.1% YoY Gross margin
31.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-10
Labcorp Holdings Inc. Q4 FY2021 Earnings Call
Revenue
$1.07B*
▼ 76.1% YoY Gross margin
69.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Labcorp Holdings Inc. Q3 FY2021 Earnings Call
Revenue
$4.06B
▲ 4.3% YoY Diluted EPS
$5.20
▼ 15.6% YoY Gross margin
34.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Labcorp Holdings Inc. Q2 FY2021 Earnings Call
Revenue
$3.84B
▲ 38.7% YoY Diluted EPS
$4.09
▲ 100.8% YoY Gross margin
32.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-29
Labcorp Holdings Inc. Q1 FY2021 Earnings Call
Revenue
$4.16B
▲ 47.4% YoY Diluted EPS
$6.72
Gross margin
38.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-11
Labcorp Holdings Inc. Q4 FY2020 Earnings Call
Revenue
$4.49B*
▲ 52% YoY Gross margin
42.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-27
Labcorp Holdings Inc. Q3 FY2020 Earnings Call
Revenue
$3.90B
▲ 33% YoY Diluted EPS
$6.16
▲ 218.7% YoY Gross margin
40.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-28
Labcorp Holdings Inc. Q2 FY2020 Earnings Call
Revenue
$2.77B
▼ 3.9% YoY Diluted EPS
$2.04
▲ 22.8% YoY Gross margin
27.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-29
Labcorp Holdings Inc. Q1 FY2020 Earnings Call
Revenue
$2.82B
▲ 1.2% YoY Diluted EPS
$-2.81
▼ 275.8% YoY Gross margin
25.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-13
Labcorp Holdings Inc. Q4 FY2019 Earnings Call
Revenue
$2.95B
▲ 6% YoY Diluted EPS
$1.99
▲ 48.7% YoY Gross margin
27.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–28 of 28 earnings calls
Key facts
CIK
920148
CUSIP
504922105
13F (30d)
943 filings
906 filers
Visit website
Investor relations